New device aims to prevent mouth sores and tube slippage in elderly ICU patients
NCT ID NCT07684443
First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time
Summary
This trial tests whether a special device (AnchorFast) can better secure breathing tubes in elderly trauma patients compared to standard tape. The goal is to reduce painful mouth injuries and prevent the tube from slipping out. Ninety patients aged 65 and older in the intensive care unit will be randomly assigned to one of three securing methods.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- AnchorFast endotracheal tube securement device
- What this could lead to
- If effective, this device could become a standard way to secure breathing tubes in elderly ICU patients, reducing painful mouth sores and accidental tube removal.
- What could go wrong
- This is a small, early-stage trial with only 90 patients, so results may not apply to all hospital settings. The device may not significantly outperform tape.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
90 people
The number who actually took part.
- Started
-
Dec 2025
- Finished
-
May 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
65 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Inclusion Criteria 1. Age ≥65 years old and more. 2. Newly admission to trauma ICU following traumatic injury 3. Patient attached with EET and mechanical ventilation 4. Expected duration of mechanical ventilation for 72 hours and more. 5. Hemodynamically stable (MAP ≥65 mmHg with or without vasopressors) 6. Informed consent obtained from patient or legally authorized representative 7. Enrollment within 6 hours of intubation Exclusion Criteria: * Extubation: 1. Pre-existing tracheostomy and planned tracheostomy within 72 hours 2. Patients with facial trauma or facial burns or active facial skin. 3. Known allergy to adhesive materials or device components 4. Active facial skin infection or significant dermatologic condition 5. Enrollment in another interventional study 6. Do-not-resuscitate status or comfort care designation 7. Expected survival less than 72 hours based on clinical judgment 8. Oral surgery or oral infection or inflammation. 9. A previous neck injury, projecting upper teeth, or the absence of teeth. 10. Radiotherapy-induced oral mucositis.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Elderly are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Norther Private Colleague of Nursing
Arar, Saudi Arabia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a toothbrush and mouthwash cut pneumonia in the elderly?
- Can a coordinated care team reduce severe side effects in older cancer patients?
- Agility drills may sharpen both body and mind in seniors
- A 12-Week program aims to rebuild independence in elderly care
- Could a Pre-Surgery nerve block speed up recovery after hip fracture?
- Iron deficiency hidden by inflammation: a new test may see through it